URGN
UroGen Pharma Ltd. Ordinary Shares (URGN)
$40
About UroGen Pharma Ltd. Ordinary Shares (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$11.88
Daily low
$11.25
Price at open
$11.87
52 Week High
$20.70
52 Week Low
$9.03
Market cap
548.5M
Dividend yield
0.00%
Volume
479,204
Avg. volume
406,763
P/E ratio
-3.69
UroGen Pharma Ltd. Ordinary Shares News
Details
Daily high
$11.88
Daily low
$11.25
Price at open
$11.87
52 Week High
$20.70
52 Week Low
$9.03
Market cap
548.5M
Dividend yield
0.00%
Volume
479,204
Avg. volume
406,763
P/E ratio
-3.69